Trial Information

Summary: Blood Clots - Adults

Patients who are hospitalized or confined to a bed are eligible to participate in a research study that prevents formation of blood clots. This study is conducted by Long Island Jewish Medical Center.

You may be eligible to participate in this study if you:

  • Are 40 years of age or older
  • Anticipate complete immobilization during the first day of hospitalization and anticipated decreased level of mobility (bed rest) and hospital stay duration of at least 4 days

You may not participate in this study if you:

  • Have a condition that may increase bleeding
  • Have had an amputation above the knee
  • Are pregnant, breastfeeding, or intend to become pregnant during the study
  • Have participated in another research study within the last 30 days

Contact:

Rosa Gonzaga-Camfield, Study Coordinator
Biomedical Research Alliance of New York
Long Island Jewish Medical Center
270-05 76th Avenue
New Hyde Park, NY 11040
Telephone: 718-470-7260
Email:

Profile Page: Biomedical Research Alliance of New York, New Hyde Park, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:37:05 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA